Body composition and myokines in a cohort of patients with Becker muscular dystrophy

被引:4
|
作者
Barp, Andrea [1 ]
Carraro, Elena [1 ]
Goggi, Giovanni [2 ,3 ]
Lizio, Andrea [1 ]
Zanolini, Alice [1 ]
Messina, Carmelo [4 ]
Perego, Silvia [5 ]
Verdelli, Chiara [6 ]
Lombardi, Giovanni [5 ,7 ]
Sansone, Valeria Ada [1 ]
Corbetta, Sabrina [2 ,8 ]
机构
[1] Univ Milan, NeMO Clin Ctr, Neurorehabil Unit, Piazza Osped Maggiore 3, I-20162 Milan, Italy
[2] IRCCS Ist Ortoped Galeazzi, Endocrinol & Diabetol Serv, Milan, Italy
[3] Univ Milan, Dept Biotechnol & Translat Med, Milan, Italy
[4] IRCCS Ist Ortoped Galeazzi, Milan, Italy
[5] IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy
[6] IRCCS Ist Ortoped Galeazzi, Lab Expt Endocrinol, Milan, Italy
[7] Poznan Univ Phys Educ, Dept Athlet Strength & Conditioning, Poznan, Poland
[8] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy
关键词
Becker muscular dystrophy; bone mineral density; Duchenne muscular dystrophy; DXA; Irisin; X-RAY ABSORPTIOMETRY; BONE-MINERAL DENSITY; SKELETAL-MUSCLE; OSTEOPOROTIC FRACTURES; DIAGNOSTIC-CRITERIA; MASS; SARCOPENIA; IRISIN; PROTEIN; QUANTIFICATION;
D O I
10.1002/mus.27565
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction/Aims Becker muscular dystrophy (BMD) is an X-linked disease leading to muscle wasting and weakness. The decrease in lean body mass (LBM) in Duchenne muscular dystrophy, has shown correlation with loss of muscle function and bone density (BD). Myokines (including irisin) are hormones secreted by skeletal muscle that allow crosstalk between muscle and bone. The present study analyzed body composition and circulating myokine levels in a cohort of BMD patients; moreover, the association between dual energy X-ray absorptiometry (DXA) parameters, functional motor assessments, and myokine levels was investigated. Methods All patients underwent DXA, blood samples for myokine assays, and functional motor assessments. A group of healthy controls (HCs) was also included. Results Thirty BMD patients, median age at evaluation 36.0 y [26.0-41.0], were included. Twenty-nine patients underwent whole-body DXA. Median value of total body Z-score was -0.70. The prevalence of low skeletal muscle mass defined as appendicular skeletal muscle mass index (ASMMI) < 7.59 kg/m(2) was 83%. Irisin levels were significantly lower in BMD compared to HCs (p = .03). All DXA parameters showed significant correlation with the functional motor assessments, in particular the h(2)-standardized lean mass lower limb index (p = .0006); h(2)-standardized total fat mass showed negative correlations with North Star Ambulatory Assessment and 6 min walk test (p = .03). Discussion DXA is a useful tool to evaluate body composition in BMD patients; the decrease in BD and LBM is associated with a reduction of motor function in BMD.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 50 条
  • [41] Homozygous Female Becker Muscular Dystrophy
    Fujii, Katsunori
    Minami, Narihiro
    Hayashi, Yukiko
    Nishino, Ichizo
    Nonaka, Ikuya
    Tanabe, Yuzo
    Takanashi, Jun-ichi
    Kohno, Yoichi
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2009, 149A (05) : 1052 - 1055
  • [42] Muscle MRI in Becker muscular dystrophy
    Tasca, Giorgio
    Iannaccone, Elisabetta
    Monforte, Mauro
    Masciullo, Marcella
    Bianco, Flaviana
    Laschena, Francesco
    Ottaviani, Pierfrancesco
    Pelliccioni, Marco
    Pane, Marika
    Mercuri, Eugenio
    Ricci, Enzo
    NEUROMUSCULAR DISORDERS, 2012, 22 : S100 - S106
  • [43] Update in Duchenne and Becker muscular dystrophy
    Waldrop, Megan A.
    Flanigan, Kevin M.
    CURRENT OPINION IN NEUROLOGY, 2019, 32 (05) : 722 - 727
  • [44] Comparison of Serum rAAV Serotype-Specific Antibodies in Patients with Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Inclusion Body Myositis, or GNE Myopathy
    Zygmunt, Deborah A.
    Crowe, Kelly E.
    Flanigan, Kevin M.
    Martin, Paul T.
    HUMAN GENE THERAPY, 2017, 28 (09) : 737 - 746
  • [45] Duchenne and Becker muscular dystrophy in adolescents: current perspectives
    Andrews, Jennifer G.
    Wahl, Richard A.
    ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2018, 9 : 53 - 63
  • [46] Cardiomyopathy in becker muscular dystrophy: Overview
    Ho, Rady
    Nguyen, My-Le
    Mather, Paul
    WORLD JOURNAL OF CARDIOLOGY, 2016, 8 (06): : 356 - 361
  • [47] Investigational treatments and therapeutic targets in Becker muscular dystrophy
    Matsuo, Masafumi
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (07): : 821 - 829
  • [48] Duchenne and Becker muscular dystrophy - A molecular and immunohistochemical approach
    Freund, Aline Andrade
    Scola, Rosana Herminia
    Arndt, Raquel Cristina
    Lorenzoni, Paulo Jose
    Kay, Claudia Kamoy
    Werneck, Lineu Cesar
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (01) : 73 - 76
  • [49] Diagnosis and therapy of Duchenne and Becker forms of muscular dystrophy
    Kirschner, J.
    MEDIZINISCHE GENETIK, 2009, 21 (03) : 322 - 326
  • [50] Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis
    Wang, Junjie
    Fan, Qin
    Yu, Tengbo
    Zhang, Yingze
    BMC GENOMIC DATA, 2021, 22 (01):